Malignant potential in pancreatic neoplasm; new insights provided by circulating miR-223 in plasma
暂无分享,去创建一个
D. Ichikawa | H. Taniguchi | E. Otsuji | A. Shiozaki | S. Komatsu | K. Okamoto | H. Konishi | H. Ikoma | R. Morimura | T. Ohashi | T. Imamura | T. Kawaguchi | M. Miyamae | S. Hirajima | W. Okajima | Mahito Miyamae | Takuma Ohashi | Wataru Okajima | Taisuke Imamura
[1] Zhao-hui Zhong,et al. MiR-223-3p targeting SEPT6 promotes the biological behavior of prostate cancer , 2014, Scientific Reports.
[2] N. Tanaka,et al. Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer , 2014, International journal of oncology.
[3] T Kawaguchi,et al. Plasma microRNA profiles: identification of miR-25 as a novel diagnostic and monitoring biomarker in oesophageal squamous cell carcinoma , 2014, British Journal of Cancer.
[4] T. Skaar,et al. Incubation of Whole Blood at Room Temperature Does Not Alter the Plasma Concentrations of MicroRNA-16 and -223 , 2013, Drug Metabolism and Disposition.
[5] D. Ichikawa,et al. Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma , 2013, British Journal of Cancer.
[6] D. Ichikawa,et al. Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer , 2013, British Journal of Cancer.
[7] D. Ichikawa,et al. Prognostic impact of circulating miR-21 and miR-375 in plasma of patients with esophageal squamous cell carcinoma , 2012, Expert opinion on biological therapy.
[8] D. Ichikawa,et al. Circulating microRNA in digestive tract cancers. , 2012, Gastroenterology.
[9] F. Lo‐Coco,et al. Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expression. , 2012, Blood.
[10] T Kawaguchi,et al. Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma , 2012, British Journal of Cancer.
[11] T. Itoi,et al. Randomized phase II study of gemcitabine and S-1 combination versus gemcitabine alone in the treatment of unresectable advanced pancreatic cancer (Japan Clinical Cancer Research Organization PC-01 study) , 2012, Cancer Chemotherapy and Pharmacology.
[12] E. Kroh,et al. Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies , 2011, Cancer Prevention Research.
[13] K. Mimori,et al. Overexpression of microRNA-223 regulates the ubiquitin ligase FBXW7 in oesophageal squamous cell carcinoma , 2011, British Journal of Cancer.
[14] Hamid Cheshmi. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers , 2011 .
[15] D. Ichikawa,et al. Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma , 2011, British Journal of Cancer.
[16] Hongwei Zhang,et al. miRNA-223 Promotes Gastric Cancer Invasion and Metastasis by Targeting Tumor Suppressor EPB41L3 , 2011, Molecular Cancer Research.
[17] E. Kroh,et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma , 2011, Proceedings of the National Academy of Sciences.
[18] K. Vickers,et al. MicroRNAs are Transported in Plasma and Delivered to Recipient Cells by High-Density Lipoproteins , 2011, Nature Cell Biology.
[19] C. Compton,et al. TNM seventh edition: What's new, what's changed , 2010, Cancer.
[20] Takahiro Ochiya,et al. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis , 2010, Cancer science.
[21] A. Masamune,et al. Prediction of invasive carcinoma in branch type intraductal papillary mucinous neoplasms of the pancreas , 2010, Journal of Gastroenterology.
[22] D. Ichikawa,et al. Circulating microRNAs in plasma of patients with gastric cancers , 2010, British Journal of Cancer.
[23] T. Okumura,et al. Pancreatic Ductal Adenocarcinomas in Long-Term Follow-Up Patients With Branch Duct Intraductal Papillary Mucinous Neoplasms , 2010, Pancreas.
[24] Masao Tanaka,et al. Predictors of the Presence of Concomitant Invasive Ductal Carcinoma in Intraductal Papillary Mucinous Neoplasm of the Pancreas , 2010, Annals of surgery.
[25] Fedor V. Karginov,et al. Cell contact-dependent acquisition of cellular and viral nonautonomously encoded small RNAs. , 2009, Genes & development.
[26] A. Jemal,et al. Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.
[27] Jacopo Meldolesi,et al. Shedding microvesicles: artefacts no more. , 2009, Trends in cell biology.
[28] X. Chen,et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.
[29] Daniel B. Martin,et al. Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.
[30] H. Iishi,et al. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas , 2008, Gut.
[31] R. Labianca,et al. Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer , 2008, BMC Cancer.
[32] W. Filipowicz,et al. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? , 2008, Nature Reviews Genetics.
[33] T. Davison,et al. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma , 2007, Oncogene.
[34] L. Lim,et al. A microRNA component of the p53 tumour suppressor network , 2007, Nature.
[35] Catrin Tudur Smith,et al. Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] J. Lötvall,et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.
[37] C. Croce,et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. , 2007, JAMA.
[38] A. Akobeng,et al. Understanding diagnostic tests 3: receiver operating characteristic curves , 2007, Acta paediatrica.
[39] K. Hirata,et al. Current Status of Surgery for Pancreatic Cancer , 2007, Digestive Surgery.
[40] C. Croce,et al. MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.
[41] S. Lowe,et al. A microRNA polycistron as a potential human oncogene , 2005, Nature.
[42] H. Horvitz,et al. MicroRNA expression profiles classify human cancers , 2005, Nature.
[43] T. Ohtsuka,et al. Intraductal Papillary-Mucinous Tumor of the Pancreas Concomitant with Ductal Carcinoma of the Pancreas , 2002, Pancreatology.
[44] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[45] U. Reinhold,et al. Extracellular tyrosinase mRNA within apoptotic bodies is protected from degradation in human serum. , 2001, Clinical chemistry.
[46] M. Pfaffl,et al. A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.
[47] V. Ambros,et al. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.
[48] 森村 玲. Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer , 2012 .
[49] L. Tanoue. Cancer Statistics, 2009 , 2010 .
[50] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.